Advertisement

Serotonin and Smooth Muscle

  • A. L. Killam
  • M. L. Cohen
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 111)

Abstract

Serotonin as an endogenous neurotransmitter has been implicated in the pathophysiology of diseases involving many smooth muscle systems including hypertension, migraine, Raynaud’s phenomenon, vasospasm of the coronary and the cerebral vasculature, gut motility disorders, and dysfunction of genitourinary smooth muscle. Compared to our knowledge of the cholinergic and adrenergic systems, the precise involvement of serotonin in both the physiological and pathological functions of smooth muscle has remained elusive.

Keywords

Contractile Response Serotonin Receptor Porcine Coronary Artery Serotonin Receptor Subtype Esophageal Smooth Muscle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aas P (1983) Serotonin induced release of acetylcholine from neurons in the bronchial smooth muscle of the rat. Acta Physiol Scand 117:477–480PubMedCrossRefGoogle Scholar
  2. Adham N, Romanienko P, Hartig P, Weinshank RL, Branchek T (1992) The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D receptor. Mol Pharmacol 41:1–7PubMedGoogle Scholar
  3. Baez M, Yu L, Cohen ML (1990) Pharmacological and molecular evidence that the contractile response to serotonin in rat stomach fundus is not mediated by activation of the 5-hydroxytryptamine1C receptor. Mol Pharmacol 38:31–37PubMedGoogle Scholar
  4. Baez M, Yu L, Cohen ML (1991) Is contraction to serotonin mediated via 5-HT1C receptor activation in rat stomach fundus? In: Fozard JR, Saxena PR (eds) Serotonin molecular biology, receptors and functional effects. Birkhäuser, Basel, pp 144–152Google Scholar
  5. Baird AW, Cuthbert AW (1987) Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia. Br J Pharmacol 92:647–655PubMedGoogle Scholar
  6. Baumgartner RA, Wills-Karp M, Kaufman MJ, Munakatos M, Hirshman C (1990) Serotonin induces constriction and relaxation of the guinea pig airway. J Pharmacol Exp Ther 255:165–173PubMedGoogle Scholar
  7. Baxter GS, Craig DA, Clarke DE (1991) 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosa. Naunyn Schmiedebergs Arch Pharmacol 345:439–446Google Scholar
  8. Berendsen HHG, Broekkamp CLE (1987) Drug-induced penile erections in rats: indications of serotonin1B receptor mediation. Eur J Pharmacol 135:279–287PubMedCrossRefGoogle Scholar
  9. Berendsen HHG, Jenck F, Broekkamp CLE (1990) Involvement of 5-HT1C-receptors in drug-induced penile erections in rats. Psychopharmacology (Berlin) 101:57–61CrossRefGoogle Scholar
  10. Bhattacharyya D, Bhattacharjee S, Naq BN, Maity CR, Bandyopodhyay SK (1990) Biochemical evidence for a mediatory role of 5-hydroxytryptamine in the uterotonic action of prostaglandin F. Mater Med Pol 22:194–197PubMedGoogle Scholar
  11. Blauw GJ, von Brummelen P, van Zwieten PA (1988) Serotonin induced vasodilation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205–930. Life Sci 43:1441–1449PubMedCrossRefGoogle Scholar
  12. Bodelsson M, Torenbrandt K, Arneklo-Nobin (1993) Endothelial relaxing 5-hydroxytryptamine receptors in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 342:130–135Google Scholar
  13. Borton M, Docherty JR (1990) The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 342:130–135PubMedCrossRefGoogle Scholar
  14. Bradley PB, Engel G, Fenuik W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576PubMedCrossRefGoogle Scholar
  15. Branchek T (1993) More serotonin receptors? Current Biol 3:315–317CrossRefGoogle Scholar
  16. Brodie TG (1900–1901) The immediate action of an intravenous injection of blood serum. J Physiol 26:48–71PubMedGoogle Scholar
  17. Buchheit K-H, Engel G, Mutschler E, Richardson B (1985) Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 329:36–41PubMedCrossRefGoogle Scholar
  18. Buchheit KH, Buscher HH, Gourese R (1990) The antiemetic profile of the 5-HT3 receptor antagonist, ICS 205–930 and its quaternary derivative. The second IUPHAR satellite meeting on serotonin. Abstr #148.Google Scholar
  19. Buckner CK, Dea D, Liberati N, Krell RD (1991) A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig. J Pharmacol Exp Ther 257:26–34PubMedGoogle Scholar
  20. Buckner CK, Saban R, Hand JM, Laravuso RM, Will JA (1987) Pharmacological studies of contractile and relaxant responses to serotonin in extralobar pulmonary arteries isolated from the guinea pig. In: Dawson CA, Weir EK, Buckner CH (eds) The pulmonary circulation in health and disease. New York Academy Press, New York, pp 109–128Google Scholar
  21. Bunce KT, Elswood CJ, Ball MT (1991) Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon. Br J Pharmacol 102:811–816PubMedGoogle Scholar
  22. Burleigh DW (1977) Evidence for more than one type of 5-hydroxytryptamine receptor in the human colon. J Pharm Pharmacol 29:538–541PubMedCrossRefGoogle Scholar
  23. Butler A, Elswood CJ, Burridge J, Ireland SJ, Bunce KT, Kilpatrick GJ, Typers MB (1990) The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol 101:591–598PubMedGoogle Scholar
  24. Campos-Lara G, Caracheo F, Valencia-Sanchez A, Ponce-Monter H (1990) The sensitivity of rat uterus to serotonin in vitro is a late estrogenic response. Arch Invest Med 21:71–75Google Scholar
  25. Chappie CR, Crowe R, Gilpin SA, Gosling J, Burnstock G (1991) The innervation of the human prostate gland — the changes associated with benign enlargement. J Urol 146:1637–1644Google Scholar
  26. Chedotal A, Hamel E (1990) Serotonin-synthesizing nerve fibers in rat and cat cerebral arteries and arterioles: immunohistochemistry of tryptophan-5-hydroxylase. Neurosci Lett 116(3):269–274PubMedCrossRefGoogle Scholar
  27. Chen H-I (1990) Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract. Br J Pharmacol 101:212–216PubMedGoogle Scholar
  28. Chester AH, Martin GR, Bodelsson M, Arneklo-Nobin B, Tadjkarimi S, Tornebrandt K, Yacoub MH (1990) 5-hydroxytryptamine receptor profile in healthy and diseased human coronary arteries. Cardio vase Res 24:932–937CrossRefGoogle Scholar
  29. Cho CH, Ogle CW (1986) The inhibitory action of 5-hydroxytryptamine on gastric secretory function in rats. Br J Pharmacol 87:371–377PubMedGoogle Scholar
  30. Clancy BM, Maayani S (1985) 5-hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogues. J Pharmacol Exp Ther 233:761–769PubMedGoogle Scholar
  31. Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL (1985) Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235:696–708PubMedGoogle Scholar
  32. Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–630PubMedCrossRefGoogle Scholar
  33. Cohen ML (1988) Serotonin receptors in vascular smooth muscle. In: Sanders-Bush E (ed) The serotonin receptors. Humana, Clifton, pp 295–318CrossRefGoogle Scholar
  34. Cohen ML (1989) 5-hydroxytryptamine and non-vascular smooth muscle contraction and relaxation. In: Fozard JR (ed) The peripheral actions of 5-hydroxytryptamine. Oxford University Press, New York, pp 201–217Google Scholar
  35. Cohen ML (1992) 5-HT3 receptors in the periphery. In: Hamon M (ed) Central and peripheral 5-HT3 receptors. Academic, New York, pp 19–32Google Scholar
  36. Cohen ML, Carpenter R, Schenck K, Wittenauer L, Mason N (1986) Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein. J Pharmacol Exp Ther 238:860–867PubMedGoogle Scholar
  37. Cohen ML, Colbert WE (1986) Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors. J Pharmacol Exp Ther 237(3):713–718PubMedGoogle Scholar
  38. Cohen ML, Drey K (1989) Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat. J Pharmacol Exp Ther 248(3):1063–1068PubMedGoogle Scholar
  39. Cohen ML, Fludzinski LA (1987) Contractile serotonergic receptor in rat stomach fundus. J Pharmacol Exp Ther 243(1):264–269PubMedGoogle Scholar
  40. Cohen ML, Fuller RW, Wiley KS (1981) Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther 218(2):421–425PubMedGoogle Scholar
  41. Cohen ML, Schenck KW, Colbert W, Wittenauer (1985) The role of 5-HT2 receptors in serotonin-induced contractions of peripheral non-vascular smooth muscle. J Pharmacol Exp Ther 232:770–774PubMedGoogle Scholar
  42. Cohen ML, Schenck K, Nelson D, Robertson DW (1992) Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veins. Eur J Pharmacol 211:43–46PubMedCrossRefGoogle Scholar
  43. Cohen ML, Wittenauer LA (1987) Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle. J Cardiovasc Pharmacol 10:176–181PubMedCrossRefGoogle Scholar
  44. Cohen RA, Zitnay KM, Weisbrod RM (1987) Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimai damage in vivo. Circ Res 61:829–833PubMedGoogle Scholar
  45. Connor HE, Feniuk W, Humphrey PPA (1989) 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol 161:91–94PubMedCrossRefGoogle Scholar
  46. Craig DA, Clarke DE (1990) Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine4 receptor. J Pharmacol Exp Ther 252(3): 1378–1386PubMedGoogle Scholar
  47. Crowe R, Burnstock G, Dickinson IK, Pryor JP (1991a) The human penis: an unusual penetration of NPY-immunoreactive nerves within the medial muscle coat of the deep dorsal vein. J Urol 145:1292–1296PubMedGoogle Scholar
  48. Crowe R, Chappie CR, Burnstock G (1991b) The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine β-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia. Br J Urol 68:53–61PubMedCrossRefGoogle Scholar
  49. Cushing DJ, Cohen ML (1992) Relaxant serotonin receptor in canine coronary smooth muscle. J Pharmacol Exp Ther 263:123–129PubMedGoogle Scholar
  50. Davis NS (1987) Determination of serotonin and 5-hydroxyindoleacetic acid in guinea pig and human prostate using HPLC. Prostate 11:353–360PubMedCrossRefGoogle Scholar
  51. De Chaffoy de Courcelles D, deClerck F (1990) The human platelet 5-HT2-receptor: an up-date. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine. Kluwer, Dordrecht, pp 445–457Google Scholar
  52. Di Sant’Agnese PA, Davis NS, Chen M, De Mesy Jensen KL (1987) Age-related changes in the neuroendocrine (endocrine-paracrine) cell population and the serotonin content of the guinea pig prostate. Lab Invest 57(6):729–736PubMedGoogle Scholar
  53. Dumuis A, Bohelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with cyclase in the central nervous system. Mol Pharmacol 34:880–887PubMedGoogle Scholar
  54. Edvinsson L, Birath E, Uddman R, Lee TJ-F, Duverger D, MacKenize ET, Scatton B (1984) Indoleaminergic mechanisms in brain vessels: localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine. Acta Physiol Scand 121:291–299PubMedCrossRefGoogle Scholar
  55. Eglen RM, Swank SR, Walsh LKM, Whiting RL (1990) Characterization of 5-HT3 and “atypical” 5-HT receptors mediating guinea-pig ileal contractions in vitro. Br J Pharmacol 101:513–520PubMedGoogle Scholar
  56. Elswood CJ, Bunce KT, Humphrey PPA (1991) Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol 196:149–155PubMedCrossRefGoogle Scholar
  57. Engel G, Hoyer D, Kalkman HO, Wick MB (1984) Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res 4:113–126PubMedGoogle Scholar
  58. Erlander MG, Lovenberg TW, Baron BM, Delecea L, Danielson PE, Racke M, Slone AL, Siegel BW, Foye PE, Cannon K, Burns JE, Sutcliffe JG (1993) Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc Natl Acad Sci USA 90:3452–3456PubMedCrossRefGoogle Scholar
  59. Erspamer V (1966) Peripheral physiological and pharmacological actions of indolealkylamines. In: Erspamer V (ed) Handbook of experimental pharmacology, vol 14. Springer, Berlin Heidelberg New York, pp 245–359Google Scholar
  60. Erspamer V, Asero B (1952) The identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800–801PubMedCrossRefGoogle Scholar
  61. Fargin A, Raymind JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335:358–360PubMedCrossRefGoogle Scholar
  62. Fenuik W, Humphrey PPA, Watts AD (1983) 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol 96:71–78CrossRefGoogle Scholar
  63. Finberg JPM, Vardi Y (1990) Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. Br J Pharmacol 101(3):698–702PubMedGoogle Scholar
  64. Flavahan NA, Shimokawa H, Vanhoutte PM (1989) Pertusis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine arteries. J Physiol (Lond) 408:549–560Google Scholar
  65. Foreman MM, Hall JL, Love RL (1989) The role of the 5HT2 receptor in the regulation of sexual performance of male rats. Life Sci 45:1263–1270PubMedCrossRefGoogle Scholar
  66. Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ (1992) Preclinical studies on LY237733, a potent and selective serotonergic antagonist. J Pharmacol Exp Ther 260(1):51–57PubMedGoogle Scholar
  67. Fox AJ, Morton IKM (1990) An examination of the 5-HT3 receptor mediating contraction and evoked [3H]-acetylcholine release in the guinea-pig ileum. Br J Pharmacol 101:553–558PubMedGoogle Scholar
  68. Fozard JR, Kilbinger H (1985) 8-OH DPAT inhibits transmitter release from guinea pig enteric cholinergic neurons by activating 5-HT1A receptors. Br J Pharmacol 86:601PGoogle Scholar
  69. Frenken M, Kaumann AJ (1984) Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharmacol 326:334–339PubMedCrossRefGoogle Scholar
  70. Furchgott RF (1955) Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J Pharmacol Exp Ther 111:265–284Google Scholar
  71. Furuhashi N, Tsujiei M, Kimura H, Yajima A (1991) Effects of ketanserin-a serotonin receptor antagonist-on placental blood flow, placental weight and fetal weight of spontaneously hypertensive rats and normal Wistar Kyoto rats. Gynecol Obstet Invest 32:65–67PubMedCrossRefGoogle Scholar
  72. Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12:323–328Google Scholar
  73. Gershon MD, Wade PR, Kirchgessner AL, Tamir H (1990) 5-HT receptor subtypes outside the central nervous system: roles in the physiology of the gut. Neuropsychopharmacology 3(5–6):385–395PubMedGoogle Scholar
  74. Gidda JS, Evans DC, Krushinski JH, Robertson DW (1991) Differential effects of quaternized 5HT3 antagonists in cisplatin-induced emesis in dogs and ferrets. Serotonin 1991, Birmingham University, July 14–17Google Scholar
  75. Gillis CN, Roth JA (1976) Pulmonary disposition of circulating vaso-active hormones. Biochem Pharmacol 25:2547–2553PubMedCrossRefGoogle Scholar
  76. Giordano J, Rogers L (1989) Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 170:83–86PubMedCrossRefGoogle Scholar
  77. Glusa E, Richter M (1993) Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn Schmiedebergs Arch Pharmacol 347: 471–477PubMedCrossRefGoogle Scholar
  78. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, Indolfi C, Russolillo E, Condorelli M, Chiariello M (1991) Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 324(10):641–648PubMedCrossRefGoogle Scholar
  79. Gothert M, Molderings GJ, Fink K, Schlicker E (1991) Heterogeneity of presynaptic serotonin receptors on sympathetic neurons in blood vessels. Blood Vessels 28:11–18PubMedGoogle Scholar
  80. Gyermek L (1962) Action of 5-hydroxytryptamine on the urinary bladder of the dog Arch Int Pharmacodyn 137(1–2):137–144PubMedGoogle Scholar
  81. Hamblin M, Metcalf M (1991) Primary structure and characterization of a human 5-HT1D receptor. Mol Pharmacol 40:143–148PubMedGoogle Scholar
  82. Hamon M (ed) (1992) Central and peripheral 5-HT3 receptors. Academic, New YorkGoogle Scholar
  83. Hartig PR (1989) Molecular biology of 5-HT receptors. Trends Pharm Sci 10:64–69PubMedCrossRefGoogle Scholar
  84. Hayashi T, Iwana A, Nagai K, Ichida S (1984) Increase of serotonin receptors (specific [3H]ketanserin binding) in rat uterine membrane fractions induced by estradiol. Jpn J Pharmacol 36:180CrossRefGoogle Scholar
  85. Hen R (1992) Of mice and flies: commonalities among 5-HT receptors. Trends Pharm Sci 13:160–165PubMedCrossRefGoogle Scholar
  86. Hills J, Meldrum LA, Klarskov P, Burnstock G (1984) A novel non-adrenergic, non-cholinergic nerve-mediated relaxation of the pig bladder neck: an examination of possible neurotransmitter candidates. Eur J Pharmacol 99:287–293PubMedCrossRefGoogle Scholar
  87. Holt SE, Cooper M, Wyllie JH (1986) On the nature of the receptor mediating the action of 5-hydroxytryptamine in potentiating responses of the mouse urinary bladder strip to electrical stimulation. Naunyn Schmiedebergs Arch Pharmacol 334:333–340PubMedCrossRefGoogle Scholar
  88. Hong E, Villalon CM (1988) External carotid vasodilation induced by serotonin and indorenate. Proc West Pharmacol Soc 31:99–101PubMedGoogle Scholar
  89. Houston DS, Vanhoutte PM (1988) Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J Pharmacol Exp Ther 244:1–10PubMedGoogle Scholar
  90. Humphrey PP, Feniuk W, Perren MJ, Conner HE, Oxford AW (1989) The pharmacology of the novel 5-HT1-like receptor agonist, GR 43175. Cephalalgia 9(9):23–33PubMedGoogle Scholar
  91. Humphrey PP, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharm Sci 14:233–236PubMedCrossRefGoogle Scholar
  92. Ichida S, Hayashi T, Terao M (1983) Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction. Eur J Pharmacol 96:155–158PubMedCrossRefGoogle Scholar
  93. Islam MS, Melville GN, Ulmer WT (1974) Role of atropine in antagonizing the effect of 5-hydroxytryptamine (5-HT) on bronchial and pulmonary vascular systems. Respiration 31:47–59PubMedCrossRefGoogle Scholar
  94. Julius D, MacDermott AB, Axel R, Jessell TM (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558–564PubMedCrossRefGoogle Scholar
  95. Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM (1990) The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci USA 87:928–932PubMedCrossRefGoogle Scholar
  96. Kao H-T, Olsen MA, Hartig PR (1989) Isolation and characterization of a human 5-HT2 receptor clone. Soc Neurosci Abstr 15:486Google Scholar
  97. Karasawa A, Kubo K, Shuto K, Nakamizo N (1985) Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation. Jpn J Pharmacol 37:285–291PubMedCrossRefGoogle Scholar
  98. Kaumann AJ, Frenken M (1985) A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors. Naunyn Schmiedebergs Arch Pharmacol 328:295–300PubMedCrossRefGoogle Scholar
  99. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1991) A 5-HT4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol 344:150–159PubMedCrossRefGoogle Scholar
  100. Kay IS, Armstrong DJ (1991) MDL 72222 (a selective 5HT3 receptor antagonist) prevents stimulation of intrapulmonary c-fibres by pulmonary embolization in anaesthetized rabbits. Exp Physiol 76:213–218PubMedGoogle Scholar
  101. Killam AL, Nikam SS, Lambert GM, Martin AR, Nelson DL (1990) Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity. J Pharmacol Exp Ther 252:1083–1089PubMedGoogle Scholar
  102. Klarskov P, Horby-Petersen J (1986) Influence of serotonin on lower urinary tract smooth muscle in vitro. Br J Urol 58:507–513PubMedCrossRefGoogle Scholar
  103. Klinge E, Sjostrand NO (1974) Contraction and relaxation of the retractor penis muscle and the penile artery of the bull. Acta Physiol Scand 93(420): 1–88Google Scholar
  104. Klinge E, Alaranta S, Sjostrand NO (1988) Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle. J Pharmacol Exp Ther 245(1): 280–286PubMedGoogle Scholar
  105. Kobilka BK, Frielle T, Collins S, Yang-Fang T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG (1987) An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329:75–79PubMedCrossRefGoogle Scholar
  106. Kojima S, Shimo Y (1986) The sites of action of 5-Hydroxytryptamine in the longitudinal muscle of the guinea pig proximal colon. Asian Pac J Pharmacol 1:111–116Google Scholar
  107. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M (1992) Molecular cloning, functional expression and pharmacological characterization of a novel serotonin receptor (5-HT2F) from rat stomach fundus. Mol Pharmacol 42: 549–557PubMedGoogle Scholar
  108. Leff P, Martin GR, Morse JM (1987) Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br J Pharmacol 91:321–331PubMedGoogle Scholar
  109. Lemoine H, Kaumann AJ (1986) Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 333:91–97PubMedCrossRefGoogle Scholar
  110. Lombardi DM, Barone FC, Ormsbee HS (1987) Excitatory serotonin receptors mediate contraction of isolated canine lower esophageal sphincter (LES). Gastroenterology 92:1509Google Scholar
  111. Longhurst PA, Belis JA, O’Donnell JP, Galie JR, Westfall DP (1984) A study of the atropine-resistant component of the neurogenic response of the rabbit urinary bladder. Eur J Pharmacol 99:295–302PubMedCrossRefGoogle Scholar
  112. Lopez de Pablo AL, Marco EJ, Benito JM, Fraile ML, Sanz ML, Moreno MJ, Conde MV (1991) Response of isolated cat middle cerebral artery to platelets: effect of endothelial removal. Gen Pharmacol 22:353–358CrossRefGoogle Scholar
  113. Lucchelli A, Santagostino-Barbone MG, Modesto F, Grana E (1984) Direct and indirect actions of 5-hydroxytryptamine on the rat isolated vas deferens. Arch Int Pharmacodyn 269:236–251PubMedGoogle Scholar
  114. Mankad PS, Chester AH, Yacoub MH (1991) 5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc Res 25:244–248PubMedCrossRefGoogle Scholar
  115. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254:432–437PubMedCrossRefGoogle Scholar
  116. Mate L, Sakamoto T, Greeley GH, Thompson JC (1985) Regulation of gastric acid secretion by secretion and serotonin. Am J Surg 149:40–45PubMedCrossRefGoogle Scholar
  117. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A (1991) Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 324(10):648–654PubMedCrossRefGoogle Scholar
  118. Meehan AG, Kreulen DL (1991) Electrophysiological studies on the interaction of 5-hydroxytryptamine with sympathetic transmission in the guinea pig inferior mesenteric artery and ganglion. J Pharmacol Exp Ther 256(1):82–87PubMedGoogle Scholar
  119. Meehan AG, Story DF (1989) Interaction of the prejunctional inhibitory action of 5-hydroxytryptamine on noradrenergic transmission with neuronal amine uptake in rabbit isolated ear artery. J Pharmacol Exp Ther 248:342–347PubMedGoogle Scholar
  120. Millar JA, Facoory BD, Laverty R (1982) Mechanism of action of ketanserin. Lancet 2:1154PubMedCrossRefGoogle Scholar
  121. Molderings GJ, Engel G, Roth E, Gothert M (1989) Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery. Naunyn Schmiedebergs Arch Pharmacol 340:300–308PubMedCrossRefGoogle Scholar
  122. Molderings GJ, Werner K, Likunger J, Gothert M (1990) Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT1D subtype. Naunyn Schmiedebergs Arch Pharmacol 342:371–377PubMedCrossRefGoogle Scholar
  123. Moritoki H, Fukuda H, Kanaya J, Ishida Y (1986a) Ketanserin potentiates the prejunctional inhibitory effect of 5-hydroxytryptamine on rat vas deferens. J Pharm Pharmacol 38:737–741PubMedCrossRefGoogle Scholar
  124. Moritoki H, Iwamoto T, Kanaya J, Ishida Y, Fukuda H (1986b) Age-related change in serotonin-mediated prejunctional inhibition of rat vas deferens. Eur J Pharmacol 132:39–46PubMedCrossRefGoogle Scholar
  125. Muller-Schweinitzer E, Engel G (1983) Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn Schmiedebergs Arch Pharmacol 324:287–292PubMedCrossRefGoogle Scholar
  126. Ng WW, Jing J, Hyman PE, Snape WJ Jr (1991) Effect of 5-hydroxytryptamine and its antagonists on colonic smooth muscle of the rabbit. Dig Dis Sci 36(2): 168–173PubMedCrossRefGoogle Scholar
  127. Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus, characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546PubMedCrossRefGoogle Scholar
  128. Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11:45–60PubMedCrossRefGoogle Scholar
  129. Peroutka SJ, McCarthy BG (1989) Sumatryptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol 163:133–136PubMedCrossRefGoogle Scholar
  130. Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]15-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16(3):687–699PubMedGoogle Scholar
  131. Peroutka SJ, Huang S, Allen GS (1986) Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors. J Pharmacol Exp Ther 237:901–906PubMedGoogle Scholar
  132. Pritchett DB, Bach AWJ, Wozny M, Taleb O, DalToso R, Shih JC, Seeburg PH (1988) Structure and functional expression of cloned rat serotonin 5HT2 receptor. EMBO J 7:4135–4140PubMedGoogle Scholar
  133. Rapport MM (1949) Serum vasoconstrictor (serotonin). V. The presence of creatinine in the complex. A proposed structure of the vasoconstrictor principle. J Biol Chem 180:961–969PubMedGoogle Scholar
  134. Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J Biol Chem 176:1243–1251PubMedGoogle Scholar
  135. Reeves JJ, Bunce KT, Humphrey PP (1991) Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol 103:1067–1072PubMedGoogle Scholar
  136. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131PubMedCrossRefGoogle Scholar
  137. Robertson DW, Cohen ML, Krushinski JH, Wong DT, Parli J, Gidda JS (1990) LY191617, A 5-HT3 receptor antagonist which does not cross the blood brain barrier. The second IUPHAR satellite meeting on serotonin, Abstr #149Google Scholar
  138. Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidyl-inositol turnover. Neuropharmacology 23:1223–1225PubMedCrossRefGoogle Scholar
  139. Ruat M, Traiffort E, Arrang J, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz J (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268–276PubMedCrossRefGoogle Scholar
  140. Saito A, Lee J-F (1986) Serotonin as an alternative transmitter in sympathetic nerves of large cerebral arteries of the rabbit. Circ Res 60:220–228Google Scholar
  141. Sanders-Bush E (1988) 5-HT receptors coupled to phosphoinositide hydrolysis. In: Sanders-Bush E (ed) The serotonin receptors. Humana, Clifton, pp 181–198CrossRefGoogle Scholar
  142. Saxena PR, Villalon CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15(7):S17–S34PubMedGoogle Scholar
  143. Saxena PR, Heiligers J, Mylecharane EJ, Tio R (1985) Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type. J Auton Pharmacol 5:101–107PubMedCrossRefGoogle Scholar
  144. Schoeffter P, Hoyer D (1989a) Is the sumatriptan (GR43175)-induced endothelium-dependent relaxation of pig coronary arteries mediated by 5-HT1D receptors? Eur J Pharmacol 166:117–119PubMedCrossRefGoogle Scholar
  145. Schoeffter P, Hoyer D (1989b) 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase: pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some β-adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 340:285–292PubMedGoogle Scholar
  146. Schoeffter P, Hoyer D (1990) 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J Pharmacol Exp Ther 252(1):387–395PubMedGoogle Scholar
  147. Selig MA, Bloomquist WM, Cohen ML, Fleisch JH (1988) Serotonin (5HT)2 receptor mediated pulmonary vascular and airway constriction in isolated guinea pig lung. FASEB J2:A1560Google Scholar
  148. Seong YH, Baba A, Matsuda T, Iwata H (1990) 5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: involvement of multiple 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 254(3): 1012–1016PubMedGoogle Scholar
  149. Sheller JR, Holtzman MJ, Skoogh B-E, Nadel JA (1982) Interaction of serotonin with vagal- and ACh-induced bronchoconstriction in canine lungs. J Appl Physiol 52(4): 964–966PubMedGoogle Scholar
  150. Shen Y, Monsma FJ, Metcalf MA Jr, Jose PA, Hamblin MW, Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 24:18200–18204Google Scholar
  151. Shimokawa H, Flavahan NA, Vanhoutte PM (1989) Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis-sensitive G protein. Circ Res 65:740–753PubMedGoogle Scholar
  152. Smith CFC, Bennett RT (1990) Characterization of the inhibitory 5-HT receptor in the rat vas deferens. Arch Int Pharmacodyn Ther 308:76–85PubMedGoogle Scholar
  153. Steidle CP, Cohen ML, Hoover DM, Neubauer BL (1989) Comparative contractile responses among ventral, dorsal, and lateral lobes of the rat prostate. Prostate 15:53–63PubMedCrossRefGoogle Scholar
  154. Sumner MJ (1991) Characterization of the 5-HT receptor mediating endothelium- dependent relaxation in porcine vena cava. Br J Pharmacol 102:938–942PubMedGoogle Scholar
  155. Sumner MJ, Feniuk W, Humphrey PPA (1989) Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br J Pharmacol 97:292–300PubMedGoogle Scholar
  156. Szabo C, Hardebo JE, Owman C (1991) An amplifying effect of exogenous and neurally stored 5-hydroxytryptamine on the neurogenic contraction in rat tail artery. Br J Pharmacol 102:401–407PubMedGoogle Scholar
  157. Szele FG, Murphy DL, Garrick NA (1988) Effects of fenfluramine, M-chlorophenyl-piperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates. Life Sci 43:1297–1303PubMedCrossRefGoogle Scholar
  158. Taylor EW, Duckies SP, Nelson DL (1986) Dissociation constants of serotonin agonists in the canine basilar artery correlate to Ki values at the 5-HT1A binding site. J Pharmacol Exp Ther 236:118–125PubMedGoogle Scholar
  159. Toda N, Okamura T (1990) Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J Pharmacol Exp Ther 253(2):676–682PubMedGoogle Scholar
  160. Tsuji T, Chilba S (1987) Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries. Arch Int Pharmacodyn Ther 286: 111–112PubMedGoogle Scholar
  161. Van Nueten JM, Leysen JE, Vanhoutte PM, Janssen PAJ (1982) Serotonergic responses in vascular and non-vascular tissues. Arch Int Pharmacodyn Ther 256:331–334PubMedGoogle Scholar
  162. Vanhoutte PM (1991) Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 17(5):S6–S12PubMedCrossRefGoogle Scholar
  163. Verbeuren TJ, Jordaens FH, Bult H, Herman AG (1988) The endothelium inhibits the penetration of serotonin and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther 244(1):276–282PubMedGoogle Scholar
  164. Wang SS, Peroutka SJ (1988) Historical perspective. In: Sanders-Bush E (ed) The serotonin receptors. Humana, Clifton, pp 1–20Google Scholar
  165. Wang Y, Baimbridge KG, Mathers DA (1991) Effect of serotonin on intracellular free calcium of rat cerebrovascular smooth muscle cells in culture. Can J Physiol Pharmacol 69:393–399PubMedCrossRefGoogle Scholar
  166. Watts SW, Cohen ML (1992) Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists. J Pharmacol Exp Ther 260:1101–1106PubMedGoogle Scholar
  167. Weinshank RL, Zgombick JM, Macchi M, Branchek TA, Hartig PR (1993) The human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci USA (in press)Google Scholar
  168. Yoshida S, Kuga T (1986) Probable pre- and postsynaptic modifications by 5-hydroxytryptamine of contractile responses to electrical stimulation of isolated guinea-pig vas deferens. Jpn J Pharmacol 41:315–323PubMedCrossRefGoogle Scholar
  169. Yu L, Nguyen H, Le H, Bloem LJ, Kozak CA, Hoffman BJ, Snutch TP, Lester HA, Davidson N, Lubbert H (1991) The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked. Mol Brain Res 11:143–149PubMedCrossRefGoogle Scholar
  170. Zhang I, Dyer DC (1991) 5-HT2 receptor stimulated calcium influx in ovine uterine artery in late pregnancy. Arch Int Pharmacodyn Ther 310:46–55PubMedGoogle Scholar
  171. Zmira N, Manpach M, Varon D, Maymon R, Bahary C (1991) Evaluation of ketanserin as a tocolytic agent in third trimester pregnant rats. Life Sci 48: 1809–1812PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • A. L. Killam
  • M. L. Cohen

There are no affiliations available

Personalised recommendations